Structure activity relationships of azostilbenes with anti-HIV activity (Meeting abstract). NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Structure activity relationships of azostilbenes with anti-HIV activity (Meeting abstract).

Proc Annu Meet Am Assoc Cancer Res; 35:A2008 1994. Unique Identifier : AIDSLINE ICDB/95603694
Zalkow LH; Burgess EM; Gruszecka-Kowalik E; Asibal CF; Qazi SN; Lu H; Haugwitz RD; Georgia Inst. Tech., Atlanta, GA 30332


Abstract: To facilitate the lead-optimization of anti-HIV active azostilbenes, we have developed a QSAR method that correlates chemical structures in a congeneric set with in vitro anti-HIV activities as defined by their EC50s. Congeners are mapped and ranked on the basis of their electron density distribution as specified by the wave functions derived from semiempirical molecular orbital calculations. These rankings based on e-density maps of azostilbenes, (especially those with good anti-HIV activities), correlate well with their observed EC50 values. Furthermore, this method has enabled us to define the minimum structural features of azostilbenes that are needed for anti-HIV activity. These studies have resulted in the identification of two promising leads; NSCs 634748 and 638352.
Keywords: Antiviral Agents/CHEMISTRY/*TOXICITY Azo Compounds/CHEMISTRY/*TOXICITY Comparative Study HIV/*DRUG EFFECTS Molecular Structure Stilbenes/CHEMISTRY/*TOXICITY Structure-Activity Relationship ABSTRACTKWDantiviralagents/chemistry/KWDtoxicityazocompounds/chemistry/KWDtoxicitycomparativestudyhiv/KWDdrugeffectsmolecularstructurestilbenes/chemistry/KWDtoxicitystructure-activityrelationshipabstract
950330
M9530852

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .